Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Retatrutide Injection Sites: Where to Inject and How to Rotate
educationRetatrutide (LY3437943) is injected subcutaneously once weekly into one of three DailyMed-confirmed sites: abdomen, thigh, or upper arm. This guide covers each site, how to rotate with every dose, what the label requires for prep, and which local reactions to watch for.
Zepbound (Tirzepatide) Injection Sites: Where to Inject & Rotate
educationZepbound is FDA-approved for subcutaneous injection in three sites: abdomen, thigh, and back of upper arm. This guide covers each site, how to rotate with every weekly dose, what skin to avoid, and how to track your schedule.